Biomerica Reports Second Quarter 2024 Financial Results
Revenues excluding Covid test sales increased 10.3% for the second fiscal quarter of 2024 vs the second fiscal quarter of 2023.Loss per shares narrows to...
Source: globenewswire.com
Stay updated with breaking news from Product Designed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Revenues excluding Covid test sales increased 10.3% for the second fiscal quarter of 2024 vs the second fiscal quarter of 2023.Loss per shares narrows to...
16.01.2024 - Revenues excluding Covid test sales increased 10.3% for the second fiscal quarter of 2024 vs the second fiscal quarter of 2023.Loss per shares narrows to $0.09 per share from $0.12 per share reflecting disciplined operating expense ... Seite 1